has been cited by the following article(s):
|
[1]
|
Pharmacogenetics in Tuberculosis-HIV Coinfected Populations: A Systematic Review of Genetic Variants Influencing Antiretroviral and Anti-Tuberculosis Drug Response
Journal of Multidisciplinary Healthcare,
2025
DOI:10.2147/JMDH.S555909
|
|
|
|
|
[2]
|
Electroanalytical sensors for antiretroviral drugs determination in pharmaceutical and biological samples: A review
Journal of Electroanalytical Chemistry,
2022
DOI:10.1016/j.jelechem.2022.116621
|
|
|
|
|
[3]
|
Factors Affecting the Pharmacokinetics of Pyrazinamide and Its Metabolites in Patients Coinfected with HIV and Implications for Individualized Dosing
Antimicrobial Agents and Chemotherapy,
2021
DOI:10.1128/AAC.00046-21
|
|
|
|
|
[4]
|
Model‐Based Assessment of Variability in Isoniazid Pharmacokinetics and Metabolism in Patients Co‐Infected With Tuberculosis and HIV: Implications for a Novel Dosing Strategy
Clinical Pharmacology & Therapeutics,
2020
DOI:10.1002/cpt.1806
|
|
|
|
|
[5]
|
Population Pharmacokinetics and Pharmacogenetics of Ethambutol in Adult Patients Coinfected with Tuberculosis and HIV
Antimicrobial Agents and Chemotherapy,
2020
DOI:10.1128/AAC.01583-19
|
|
|
|